Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

Clinical trial NCT01007942 · COMPLETED

Trial details

NCT number: NCT01007942
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HER2/Neu Over-expressing Locally Advanced Breast Cancer Metastatic Breast Cancer

Start date: 2009-10-01
Primary completion: 2015-06-01
Enrollment: 569

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.